Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major
- PMID: 22871617
- PMCID: PMC6080985
- DOI: 10.5144/0256-4947.2012.487
Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major
Abstract
Background and objectives: β-thalassemia results from a deficiency of β-globin chains leading to an excess in a globin chains resulting in hypochromic microcytic red cells, ineffective erythropoiesis and hemolytic anemia. It is a result of a decline of HbF synthesis during the first year of life. F-cell levels are influenced by a sequence variant (C->T) at position -158 upstream of the -globin gene, so the frequency of the Xmnl Gγ polymorphism in Egyptian patients with b-thalassemia major needed evaluation to decide on the value of HbF augmentation drugs in treating Egyptian b-thalessemia.
Design and setting: A cross-sectional study including 30 β-thalassemia major patients diagnosed and attending the Pediatric Hematology Unit, Children's University Hospital, Ain Shams University, Cairo, Egypt, in the period from October 2008 to October 2009.
Patients and methods: The 17 males and 13 females underwent a medical history and physical examination. Tests included a complete blood count, hemoglobin electrophoresis, serum ferritin, and detection of Xmnl Gγ polymorphism by PCR.
Results: The mean (SD) age was [2]10.2 (6.9) years. The most frequent genotype observed was homozygosity for the absence of the site Xmnl (-/-) in 96% of cases. Heterozygosity (+/-) genotype was detected in 4% of cases, while homozygosity for the site XmnI (+/+) genotype was absent. Genotype was not related to age at first transfusion, fetal hemoglobin level or transfusion frequency.
Conclusion: Despite the small sample size, the study demonstrated that Egyptian β-thalessemia patients have low frequency of positivity for the Xmnl polymorphism whether in heterozygous (+/-) or homozygous (+/+) state.
Figures

Similar articles
-
Frequency of Gγ-globin promoter -158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous beta thalassaemia.Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):10-5. doi: 10.1016/j.hemonc.2014.12.004. Epub 2015 Jan 6. Hematol Oncol Stem Cell Ther. 2015. PMID: 25591326
-
An Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production.BMC Med Genet. 2017 Aug 29;18(1):93. doi: 10.1186/s12881-017-0450-3. BMC Med Genet. 2017. PMID: 28851297 Free PMC article.
-
The associations of SEA-alpha thalassemia 1, XmnI-Ggamma polymorphism and beta-globin gene mutations with the clinical severity of beta-thalassemia syndrome in northern Thailand.J Med Assoc Thai. 2014 Mar;97(3):300-7. J Med Assoc Thai. 2014. PMID: 25123009
-
Genetic factors affecting clinical severity in beta-thalassemia syndromes.J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):573-80. doi: 10.1097/00043426-200011000-00026. J Pediatr Hematol Oncol. 2000. PMID: 11132233 Review.
-
Molecular basis of asymptomatic beta-thalassemia major in an African American individual.Am J Med Genet. 1997 Mar 17;69(2):196-9. Am J Med Genet. 1997. PMID: 9056561 Review.
Cited by
-
The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation.Int J Hematol Oncol Stem Cell Res. 2022 Jan 1;16(1):47-54. doi: 10.18502/ijhoscr.v16i1.8441. Int J Hematol Oncol Stem Cell Res. 2022. PMID: 35975115 Free PMC article.
References
-
- Rund D, Rachmilewitz E. β-thalassemia. N Engl J Med. 2005;353(11):1135–1146. - PubMed
-
- Agouti I, Badens C, Abouyoub A, Khattab M, Sayah F, Barakat A, Bennani M. Genotypic correlation between six common moroccan mutations of beta-thalassemia and XMN-I polymorphism. Hemoglobin. 2007;31(2):141–149. - PubMed
-
- Winichagoon P, Fucharoen S, Chen P, Wasi P. Genetic factors affecting clinical severity in betathalassemia syndromes. 2007;22(6):573–580. - PubMed
-
- Christoforidis A, Haritandi A, Tsatra I, Tsitourides I, Karyd S, Athanassiou-Metaxa M. Four- year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with β-thalassemia major: comparison between different chelation regimens. Eur J of Haemat. 2007;78(1):52–57. - PubMed
-
- El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin. 2009;33(1):S14–20. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources